Tier 3 — preclinical
Fisetin Regulates Nrf2 Expression and the Inflammation-Related Signaling Pathway to Prevent UVB-Induced Skin Damage in Hairless Mice
International Journal of Molecular Sciences
2017
Vol. 18, No. 10, page 2118
Bibliography
- PubMed
- PMID 28994699
- PubMed Central
- PMC5666800
- Funding
- This study was funded by China Medical University (CMU102-ASIA-18, CMU103-ASIA-11), Taichung, and the Ministry of Science and Technology (MOST 104-2320-B-039-006), Taipei, Taiwan.
- Competing interests
- The authors declare no conflict of interest.
Study snapshot
| Design | Preclinical in vivo animal study |
|---|---|
| Model | Female BALB/c hairless mice |
| Sample | 25 mice (5 groups of 5 mice) |
| Intervention | Topical application of fisetin (50 µM or 200 µM) following UVB irradiation |
| Duration | 10 weeks |
| Endpoints | Skin barrier function (transepidermal water loss) ; Skin erythema (a* value) ; Wrinkle formation ; Epidermal thickness ; Collagen content ; Expression levels of MMP-1, MMP-2, COX-2, IL-6, NF-κB, Nrf2, aquaporin, and filaggrin |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Fisetin: A Clinician's Guide to Evidence, Dose & SafetyFisetin is a plant flavonol with senolytic activity in selected cell and animal models. Human research now spans continuous low-dose regimens, intermittent...Read analysis
- Fisetin for Skin: Antioxidant, Senolytic, and TopicalFisetin has preclinical skin evidence from UVB, dermal-senescence and diabetic-wound models. A 2026 topical mouse study improved dermal/granulation balance and reduced fibrosis...Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



